IRIS

Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3

Mazzanti, A;Napolitano, C;PRIORI, SILVIA GIULIANA
2017-01-01
2017
Cardiovascular & Hematology Research covers all levels of investigation into the normal and pathogenic functions of the heart, vasculature, and soluble blood components. Cell biology of vascular tissue and formed elements of blood, biochemical regulation of thrombosis, therapeutic strategies for treatment of cardiac and vascular diseases are also considered. Resources on hematologic oncology are excluded and are placed in the Oncogenesis & Cancer Research category.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
sì
WOS:000392993100017
2-s2.0-85008686534
Esperti anonimi
Inglese
Internazionale
STAMPA
69
2
248
249
2
28081834
Efficacy, Mexiletine; LQTS
4
info:eu-repo/semantics/article
262
Mazzanti, A; Maragna, R; Napolitano, C; Priori, SILVIA GIULIANA
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1172845
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact